Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Kosa

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Gene|May 22, 2007
Development of a set of plasmid vectors for genetic manipulations of the pathogenic yeast Candida parapsilosisPeter Kosa, Barbora Gavenciakova, Jozef Nosek
BMC Neurology|February 5, 2025
Smartphone postural sway and pronator drift tests as measures of neurological disabilityMichael Calcagni, Peter Kosa, Bibi Bielekova
Frontiers in Neurology|December 2, 2024
Smartphone tests quantify lower extremities dysfunction in multiple sclerosisKimberly Jin, Peter Kosa, Bibiana Bielekova
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|January 26, 2006
On the origin of telomeres: a glimpse at the pre-telomerase worldJozef Nosek, Peter Kosa, Lubomir Tomaska
Medrxiv : the Preprint Server for Health Sciences|January 13, 2025
Smartphone Postural Sway and Pronator Drift tests as Measures of Neurological DisabilityMichael Calcagni, Peter Kosa, Bibi Bielekova
Frontiers in Radiology|July 26, 2023
Confounder-adjusted MRI-based predictors of multiple sclerosis disabilityYujin Kim, Mihael Varosanec, Peter Kosa, et al.
Current Genetics|June 20, 2002
Isolation of genes coding for Ade2 and Ura3 homologues from the multinuclear yeast Dipodascus magnusiiMartin Kucej, Peter Kosa, Lubica Adamíková, et al.
Medrxiv : the Preprint Server for Health Sciences|October 7, 2024
Data-driven risk/benefit estimator for multiple sclerosis therapiesBibiana Bielekova, Tianxia Wu, Peter Kosa, et al.
BMC Medicine|January 9, 2026
Extrapolating from trials to clinic: a predictive model defining the boundaries of benefit for multiple sclerosis therapies in real-world populations based on systematic reviewBibiana Bielekova, Tianxia Wu, Peter Kosa, et al.
The American Journal of Pathology|April 25, 2009
Loss of matriptase suppression underlies spint1 mutation-associated ichthyosis and postnatal lethalityRoman Szabo, Peter Kosa, Karin List, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Gene|May 22, 2007
Development of a set of plasmid vectors for genetic manipulations of the pathogenic yeast Candida parapsilosisPeter Kosa, Barbora Gavenciakova, Jozef Nosek
BMC Neurology|February 5, 2025
Smartphone postural sway and pronator drift tests as measures of neurological disabilityMichael Calcagni, Peter Kosa, Bibi Bielekova
Frontiers in Neurology|December 2, 2024
Smartphone tests quantify lower extremities dysfunction in multiple sclerosisKimberly Jin, Peter Kosa, Bibiana Bielekova
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|January 26, 2006
On the origin of telomeres: a glimpse at the pre-telomerase worldJozef Nosek, Peter Kosa, Lubomir Tomaska
Medrxiv : the Preprint Server for Health Sciences|January 13, 2025
Smartphone Postural Sway and Pronator Drift tests as Measures of Neurological DisabilityMichael Calcagni, Peter Kosa, Bibi Bielekova
Frontiers in Radiology|July 26, 2023
Confounder-adjusted MRI-based predictors of multiple sclerosis disabilityYujin Kim, Mihael Varosanec, Peter Kosa, et al.
Current Genetics|June 20, 2002
Isolation of genes coding for Ade2 and Ura3 homologues from the multinuclear yeast Dipodascus magnusiiMartin Kucej, Peter Kosa, Lubica Adamíková, et al.
Medrxiv : the Preprint Server for Health Sciences|October 7, 2024
Data-driven risk/benefit estimator for multiple sclerosis therapiesBibiana Bielekova, Tianxia Wu, Peter Kosa, et al.
BMC Medicine|January 9, 2026
Extrapolating from trials to clinic: a predictive model defining the boundaries of benefit for multiple sclerosis therapies in real-world populations based on systematic reviewBibiana Bielekova, Tianxia Wu, Peter Kosa, et al.
The American Journal of Pathology|April 25, 2009
Loss of matriptase suppression underlies spint1 mutation-associated ichthyosis and postnatal lethalityRoman Szabo, Peter Kosa, Karin List, et al.
Pageof 6